Project
Summary
Genome Technology &
Reproduction: Values & Public Policy,
herein referred to as the Project, is a three year project for developing
ethically grounded policy, professional, and institutional standards.
Through a series of interrelated and interdependent phases, the Project
identified values, attitudes and beliefs that citizens, patients, and
practitioners hold toward genetic technology. Based on the insights
and perspectives gained through a series of group processes described
below, the Project developed recommendations/approaches for public policy
and reproductive options. To address the difficulties that arise when
issues of high technical and scientific complexity merge with issues
involving emotionally charged ethical, moral, and religious views, the
Project combined several different forms of group process: lay focus
groups, community dialogues, policy meetings, and professional focus
groups. Participation included representatives from different geographic
and socio-economic groups among Michigans population. Return
to top
Focus
Group Phase
The initial phase
of the Project entailed the convening of focus groups to collect information
from different segments of the general and professional populations.
The focus groups identified value conflicts and concerns expressed by
participants through discussions on advances in genetics and their impact
on reproductive decision-making. Ideas and concerns identified during
the focus groups served as raw data for the community dialogue phase
of the project. Focus groups took place in the following Michigan cities:
Ann Arbor/Ypsilanti, Detroit, Battle Creek, and Grand Rapids.
Return
to top
Community
Dialogue Phase
For this next phase
of the Project, community dialogue groups met in Ann Arbor, Detroit,
Grand Rapids, Holland, Kalamazoo, Lansing, and Saginaw-Bay City. Each
group consisted of 30-50 community residents who agreed to meet twelve
times over a period of one year. The objectives of the community dialogue
phase were to: 1) educate large numbers of Michigan citizens about the
reproductive option issues associated with genetic technologies; 2)
open up community discussion about these issues, including those identified
in the focus groups; and 3) allow community members to transform their
moral and ethical concerns into a consensus on general values and policies
pertaining to the issues discussed.
During this phase,
the Project modeled rational democratic deliberation, a reflective and
reasoned approach to civic dialogue about controversial moral and policy
questions in our society. The twelve meetings were divided into two series
(six sessions each). The first series was aimed at capturing moral/social
value judgments while the second series tried to capture policy judgments.
At the first meeting of each of the sessions, participants responded to
case-based scenarios using computer key-pad technology that displayed
instantaneous results as graphs. Return
to top
Policy
Phase
This phase began
with a one-day conference on March 17, 1997 in Ann Arbor, Michigan.
The purpose of this conference was to link community dialogue participants
with policy-makers in order to discuss public policy options based on
information gathered during the first series of the Community Dialogues.
Attendees were state legislators, health care professionals, health
care industry leaders, and representatives from the community dialogues.
The main activity
of this phase was the consolidation of the information acquired from the
Focus Group and Community Dialogue Phases, as well as a thorough review
of the existing and proposed legislation and analogous laws related to
genetics issues. The Project investigators generated recommendations/approaches
for governmental policies, professional standards, and institutional guidelines
that reflected the values expressed by the communities in Michigan. The
investigators not only referred back to the recorded outcomes of the first
two phases, but they also actively involved the same community participants
in a meeting convened to review and refine the recommendations. The resulting
set of recommended policy approaches and professional/ institutional standards
serve as a guide to the introduction and utilization of new genetic technologies
related to reproductive decision-making. While the resulting policies
and professional/ institutional standards are directed to the legislators,
professional societies, and institutions in the State of Michigan, they
will also serve as a model for other state and national groups.
Return
to top
Dissemination
Phase
The last phase
comprises a national conference and the publications of the Projects
work. The conference, entitled Genome Horizons: Public Deliberations
& Policy Pathways, was held in Washington, DC on May 15 -16,
1998. This conference shared the Projects findings, conclusions,
and recommendations/ approaches with a national group of policy-makers
from three policy domains: legislators and legislative staff from the
federal and state levels of government; leaders of professional organizations
responsible for setting standards of practice; and leaders of the health
care providers and insurance organizations. At this working conference,
participants discussed comprehensive policy strategies and approaches
in areas such as genetic privacy, access and financing, and the new
reproductive technologies.
Publications coming
from the Project will include both articles in academic journals and publications
targeting policy-makers. In addition, a Conference
Proceedings, containing texts of all principal presentations and
summaries of the Panel discussion, question and answer sessions, and break-out
sessions, will be distributed to conference participants and other policy
leaders from the three main policy domains cited above. The Project
Policy Report was also available. Return
to top
Advisory
Sources
The Council on
Genetics & Society advised the project on issues of ethics, technology,
religion, and broader issues involving the community and public relations.
The Councils discussions on reproductive decision-making led to
the design and development of the NIH/ELSI grant.
An Expert Advisory
Committee (EAC) of national experts in law, medicine, and policy met
annually to provide broad oversight of the project, to evaluate its
overall progress, and to ensure incorporation of the latest developments
in the field. EAC members were available for telephone consultation
during the entire period of the project and served as facilitators and
panel members at the Genome Horizons Conference. Return
to top
Funding
The National Institutes
of Health, National Human Genome Research Institute - Ethical, Legal
and Social Implications Branch granted the University of Michigan, with
a subcontract to Michigan State University, $1,011,980 to conduct this
project. Return
to top
Contacting
the Project | Home
Last updated 08/07/00
Copyright © 2000 Communities of Color & Genetics Policy
Project